Nonpharmacologic Management of Insomnia Disorder in Primary Care.
Where this comes from
- Record sourced from PubMed, PMID 42120163.
- Also identified by DOI 10.1016/j.pop.2026.01.009.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Nonpharmacological treatments for insomnia disorder, particularly cognitive behavioral therapy for insomnia (CBT-I), are increasingly recognized as first-line interventions due to their long-term efficacy and safety. Unlike medications, CBT-I addresses the behavioral and cognitive patterns that perpetuate sleep disturbances, offering durable improvements without risk of dependence. Delivery formats include in-person, telehealth, and digital platforms, expanding access across diverse populations. Adaptations for children, older adults, and caregivers have shown promising results. Emerging innovations, such as AI-driven personalization and therapist-guided digital CBT-I, are shaping the future of sleep care, making evidence-based treatment more accessible, scalable, and integrated into routine health care.
Medical subject headings
- Sleep Initiation and Maintenance Disorders
- Primary Health Care
- Cognitive Behavioral Therapy